Safety, Tolerability, and Pharmacokinetics of Proxalutamide Therapy in Women With Metastatic Breast Cancer
Clinical trial NCT04103853 · COMPLETED
Trial details
- NCT number
- NCT04103853
- Sponsor
- Suzhou Kintor Pharmaceutical Inc,
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-06
- Primary completion
- 2019-05-22
- Enrollment
- 63
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.